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M´ en´ etrier’s disease is one of the rarest protein-losing gastropathies in childhood. It is characterized clinically by non-speciﬁc
gastrointestinal symptoms and edema, biochemically by hypoalbuminemia, and pathologically by enlarged gastric folds. In adults,
this disease can be devastating with signiﬁcant morbidity and mortality. In childhood, it is a self-limiting, transient and benign
illness. Its treatment is largely supportive with total parenteral nutrition (TPN) while oral intake is encouraged. Acute onset of
vomiting in healthy school age children can be initially explained by acute viral gastroenteritis. However, persistent vomiting
associatedwithhematemesisandsevereabdominalpainshouldwarrantfurtherwork-up.Thiscasereportillustratesaself-limiting
and rare cause of protein-losing enteropathy called M´ en´ etrier’s disease that presented with several variant clinical features not
typically described in association with this entity.
1.Introduction
M´ en´ etrier’s disease is an uncommon cause of protein-losing
gastropathy in children characterized by hypertrophy of
gastric folds aﬀecting the gastric body [1]. Symptoms at
onset include nausea and vomiting, with profound hypoal-
buminemia developing within a few days. The clinical course
in children is distinct from adult-onset disease. The relative
rarity of the diagnosis in combination with symptoms that
mimic nonspeciﬁc gastroenteritis at onset may delay early
recognition. This paper describes several variant clinical
featuresnottypicallydescribedinassociationwiththisentity.
2. Patient Presentation
A 7-year-old African-American female was readmitted to
our institution 4 days after discharge from the hospital with
recurrent non-bloody, nonbilious emesis. She did not have
diarrhea, fever, or skin rash. The family did not report any
sick contacts.
She had spent ten days in the hospital during the ﬁrst
admission with an episode of hematemesis, abdominal pain,
persistent nausea, and vomiting along with poor intake
requiring parenteral nutrition (PN) for 3 days. At the time
of discharge, she was tolerating a partial normal diet with
no emesis. The hospital course had been complicated by
development of gluteal abscess due to MRSA infection that
was drained along with two days of clindamycin intravenous
administration.
An esophagogastroduodenoscopy (EGD) during the ﬁrst
admission had revealed severe gastropathy with thickened
and friable mucosal folds in the gastric body and numerous
gastric erosions with evidence of recent bleeding. Tissue2 Case Reports in Gastrointestinal Medicine
and stool viral cultures had not yielded any viral growth.
The biopsy showed erosions and mild eosinophilia with
absentH.pylori.Despitetheendoscopicappearanceofsevere
gastropathy, the biopsy did not reveal foveolar hyperplasia as
is typical of M´ en´ etrier’s (Figure 1).
Laboratoryevaluationduringtheﬁrsthospitaladmission
included a normal complete blood count and comprehensive
metabolic panel but two positive tests for stool occult blood.
Urine analysis showed mild ketonuria. Hypoalbuminemia
(1.8mg/dL) was present by the third day of hospital stay.
The child had a long-standing history of frequent vom-
iting and hypersensitivity reactions to certain foods and had
received several courses of immunotherapy. Mother reported
that the child consciously restricted her intake to a diet that
consisted of bland foods such as plain pasta and bread and
showed avoidance of dairy products. Despite recent weight
loss, her BMI was at the 50th percentile.
Physical examination revealed a well-developed, but ill-
appearing child. She was afebrile with stable vital signs. Gen-
eral physical examination was notable for mild periorbital
edema and conjunctival pallor. Systemic examination was
unremarkable including absence of any abdominal ﬁndings.
Peripheral edema was absent.
Laboratory evaluation at second admission revealed
normal complete blood count, mild ketonuria, and a urine’s
speciﬁc gravity of >1030. A mild lipase elevation (62) was
present, and serum albumin of 1.7 had further decreased
to 1.4 by the third day along with a normal prealbumin.
Serum gastrin was not measured. Other studies over the
course of the hospital stay included low immunoglobulin
Ga n dMl e v e l s( I g G< 200mg/dL, IgM 27mg/dL). By
the time of discharge, immunoglobulins were normal with
the exception of improved but low IgG level (350mg/dL).
The serum albumin had remained low at 1.5. A fecal α-
1-antitrypsin level was elevated at >1.33, consistent with a
protein-losing enteropathy. Additional testing included nor-
malserumcortisollevelandnegativetissuetransglutaminase
assay.
A repeat endoscopy was performed along with a col-
onoscopy during the second admission. Endoscopy showed
edematous and thickened folds in the gastric body with
a normal-appearing gastric fundus and antrum along
with partial resolution of mucosal friability and erosions
seen previously. The gastric biopsy revealed erosions, mild
eosinophilia, along with characteristic prominent foveolar
hyperplasia (Figure 2). Mild eosinophilia was found in
duodenum, colon, and terminal ileum. A tissue culture
again failed to yield any viral growth. Ultrasound-guided
paracentesis of modest pelvic ﬂuid showed a transudate and
yielded no microbial growth.
She continued to improve over the course of the admis-
sion, with decreased abdominal pain and emesis “back to
baseline.” The plasma albumin level remained low with the
nadirof1.4g/dLalongwithpoorappetiteandintake.PNwas
initiated on the day 3 of hospital admission, with subsequent
clinical improvement. At the time of discharge, 12 days after
admission, she was tolerating 50% of her required caloric
intake and registered a weight gain of 1kg. Serum albumin
at discharge was low normal at 2.7 and increased to 3.7 at
follow-up 4 weeks later. A follow-up endoscopy one month
later showed signiﬁcant resolution of gastric hypertrophy
with absent erosions and only focal foveolar hyperplasia
(Figure 3).
3. Discussion
As of 2008, approximately 50 to 60 cases of pediatric
M´ en´ etrier’s disease are reported in the literature [2]. The
child described here exhibited signiﬁcant protein-losing en-
teropathy with profound hypoproteinemia. Other causes
of protein-losing enteropathy relevant to this case include
eosinophilic gastroenteritis, gastric lymphoma, celiac dis-
ease, hypertrophic gastropathy, in association with H. pylori
infection, and Crohn’s disease [2–5]. Published case series
favor a male and Caucasian preponderance for M´ en´ etrier’s
disease [4, 6–8].
M´ en´ etrier’s disease in children resembles the adult-onset
in its presentation with nausea, vomiting, and abdominal
pain[9].Diagnosisistypicallymadebypresenceofthickened
mucosal folds, during an upper gastrointestinal contrast
study or upper gastrointestinal endoscopy, or by ultrasound
or CT imaging [9–11]. In adults, M´ en´ etrier’s disease usually
follows a chronic, unremitting course leading to signiﬁcant
morbidityandmortalityduetoongoingproteinlossandlife-
threatening gastrointestinal hemorrhage [3, 4]. M´ en´ etrier’s
disease in children appears to be generally benign and self-
limited, with spontaneous resolution and recovery within 5
months [5, 12, 13]. An adult case series described vomiting
and edema in 50% of the group [14] with a mean serum
albumin at presentation of 1.8g/dL (range 1.5-2.5g/dL).
Generalized edema is less common being present in less than
25% [9]. In contrast, peripheral edema is reported in up
to 90% of children [3, 6]. Ascites and pleural eﬀusion can
result from pediatric M´ en´ etrier’s disease with severe protein
loss [4]. The child described did not present with clinical
ascites or peripheral edema typically present in children with
hypoalbuminemia. Hematemesis and erosive gastropathy
were also present in the child; anemia and bleeding are less
common features described in only a few papers [7, 9].
Histopathology of M´ en´ etrier’s disease is similar in adults
and children with hypertrophy of gastric glands, cystic dil-
atation of glands deep in the mucosa, an increase in
mucin secreting cells, inﬂammatory cell inﬁltration, and
thickened hyperplastic mucosa [7, 13]. The ﬁrst endoscopic
biopsy in our case showed absence of glandular dilation
or hypertrophy typical for M´ en´ etrier’s disease, conﬁrmed
on a retrospective comparative review of serial endoscopic
biopsies by a single pathologist. The biopsy from the second
endoscopy did reveal characteristic histological changes,
including foveolar hyperplasia. This discrepancy may relate
to sampling error or timing of endoscopy, being performed
earlier in the course of the disease. Moreover, endoscopy has
not always been utilized to make the diagnosis in previous
published reports. Clinicopathologic correlation is necessary
tomakeadiagnosisofM´ en´ etrier’sdisease,endoscopicbiopsy
alone being insuﬃcient.Case Reports in Gastrointestinal Medicine 3
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Figure 1: First EGD: erosion and mild eosinophilia without prominent foveolar hyperplasia (a); Endoscopic appearance of severe gas-
tropathy (b).
(a) (b)
Figure 2: Second EGD: prominent foveolar hyperplasia on gastric biopsy (a). Improved endoscopic appearance; note sparing of antrum (b).
M´ en´ etrier’s disease may be confused with eosinophilic
gastroenteritis as peripheral eosinophilia can be found in
about 66.7% of reported cases [13]. However, peripheral e-
osinophilia in eosinophilic gastroenteritis ranges from 13–
55%, higher than that usually seen in M´ en´ etrier’s disease
[15]. Burns and Gay postulated an allergic cause as the basis
ofperipheraleosinophiliaandeosinophilicmucosalinﬁltrate
[16]. Eosinophilic gastroenteritis may also present with
predominant or exclusive serosal involvement; peritoneal
ﬂuid analysis in this instance did not show eosinophils.
The gastric and duodenal biopsy from this child revealed
mild to moderate eosinophilic inﬁltration. It is unclear if
t h i si sp a r to fM´ en´ etrier’s disease histopathology or suggests
underlying eosinophilic enteritis, given a history of long-
standing vomiting with certain food triggers and food
avoidance. A subsequent food allergy evaluation did not
reveal presence of food allergens.
A deﬁnitive cause of M´ en´ etrier’s disease is still unknown
and widely debated [9]. Speculated etiology includes
chemical irritants, toxins, dietary factors, neuroemotional,
endocrinologic, or immunologic abnormalities, allergic pro-
cesses, and autoimmune disorders. The best described as-
sociation is with CMV infection. One study reported that
CMV infection was associated in 19 of 27 children with
M´ en´ etrier’s disease [17]. Another review of children with
M´ en´ etrier’sdiseasefoundanassociationwithCMVinfection
in 26 of 56 cases. Gastric biopsy showed characteristic CMV
inclusion bodies in 16 of those [9]. CMV infections are
relatively uncommon in adults with M´ en´ etrier’s disease with
the exception of immunocompromised hosts. In contrast, H.
pylori infection is more prevalent in M´ en´ etrier’s in adults
while uncommon in children [12, 18, 19]. H. pylori was
absent in all three endoscopic biopsies in the child described.
A familial form of protein-losing enteropathy with au-
tosomal dominant inheritance has been reported [20]. TGF-
α, a ligand to EGFR, may play a role in the pathogenesis
of M´ en´ etrier’s disease due to its local growth-stimulating
eﬀect via EGFR binding, leading to foveolar hyperplasia
and hypertrophic gastropathy in mice [21, 22]. This speciﬁc
mediatorisfoundtobeover-expressedinadultsandchildren
with M´ en´ etrier’s [23–25]. Suggested pathogenic mechanism
of mucosal damage caused by CMV infection may involve
the production of abnormal local TGF-α, which stimulates4 Case Reports in Gastrointestinal Medicine
(a) (b)
Figure 3: Third EGD shows persisting foveolar hyperplasia (a), erosions but improved reactive gastropathy (b).
cell proliferation of gastric mucosa, inhibits gastric secretion,
and enhances mucus secretion [26].
This African-American female child with M´ en´ etrier’s
disease exhibited several atypical features. Absence of edema,
initial presentation with erosive gastropathy, as well as pres-
ence of mild to moderate mucosal eosinophilia in the face
of long-standing vomiting with certain food triggers con-
foundedthediagnosis.M´ en´ etrier’sfeatureswereonlydiscov-
ered on subsequent endoscopic biopsies. Infectious agents
including CMV and H. pylori were absent on repeated
testing. This illustrates the importance of maintaining an
index of suspicion for this diagnosis and highlights upper
endoscopy with adequate biopsies as a useful diagnostic test
for M´ en´ etrier’s disease.
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